By Nigel Somerville, the Deputy Sheriff of AIM | Thursday 9 November 2023
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
AIM-listed ReNeuron (RENE) put out its interim results to 30 September yesterday, announcing another loss, this time of £2.8 million to bring accumulated losses to a whopping £155 million for this £3 million capitalised company. Worse still, it is running out of money….again.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.